Biostage Shares Outstanding vs. Total Debt
| BSTGDelisted Stock | USD 4.20 0.09 2.10% |
For Biostage profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biostage to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biostage utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biostage's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biostage over time as well as its relative position and ranking within its peers.
Biostage |
Biostage Total Debt vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biostage's current stock value. Our valuation model uses many indicators to compare Biostage value to that of its competitors to determine the firm's financial worth. Biostage is rated fourth in shares outstanding category among its peers. It is rated below average in total debt category among its peers making up about 0.01 of Total Debt per Shares Outstanding. The ratio of Shares Outstanding to Total Debt for Biostage is roughly 101.25 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biostage's earnings, one of the primary drivers of an investment's value.Biostage Total Debt vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Biostage |
| = | 11.64 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Biostage |
| = | 115 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Biostage Total Debt vs Competition
Biostage is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 29.55 Billion. Biostage adds roughly 115,000 in total debt claiming only tiny portion of equities under Health Care industry.
Biostage Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biostage, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biostage will eventually generate negative long term returns. The profitability progress is the general direction of Biostage's change in net profit over the period of time. It can combine multiple indicators of Biostage, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts. Biostage operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Biostage Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biostage. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biostage position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biostage's important profitability drivers and their relationship over time.
Use Biostage in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biostage position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biostage will appreciate offsetting losses from the drop in the long position's value.Biostage Pair Trading
Biostage Pair Trading Analysis
The ability to find closely correlated positions to Biostage could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biostage when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biostage - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biostage to buy it.
The correlation of Biostage is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biostage moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biostage moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biostage can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biostage position
In addition to having Biostage in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |